Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8790931 | American Journal of Ophthalmology Case Reports | 2018 | 4 Pages |
Abstract
There is no standard treatment for metastatic intraocular medulloepithelioma. The neoadjuvant chemotherapy regimen used in our patient led to regression of the extrascleral extension of the tumor, allowing for enucleation rather than a more disfiguring exenteration, as well as likely improving his prognosis. We believe that it is reasonable to consider neoadjuvant chemotherapy for patients with extrascleral and/or metastatic medulloepithelioma.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Justin B. Hellman, George J. Harocopos, Lily Koo Lin,